Fanconi Anemia Complementation Group D2 — Clinical Trials

MONDO:00092141 activeLast updated: Mar 16, 2026, 10:47 AM

Fanconi Anemia Complementation Group D2 has an emerging clinical trial program, driven by drug treatment and procedure.

Recruiting

Active Trials

Drug Treatment1

Procedure1

Phase 2

Academic/Other1

United States1 trial

Trials often recruit across multiple countries, so totals exceed the trial count.

1 Trial

Phase 2Active, Not Recruiting

Sponsor:Marc Dall'Era, MD

United StatesStarted: Feb 2020Est. completion: Dec 2025Updated: Aug 2025

Stay informed about clinical trials for Fanconi Anemia Complementation Group D2.

Follow this disease to get updates when trials open, close, or change status.

Already have an account? Sign in to manage your watchlists.

Data sourced from ClinicalTrials.gov via Kisho's automated pipeline. Trials refreshed every 4 hours for monitored diseases.

Last sync: March 16, 2026 at 10:47 AM